Monday, January 04, 2010
Sunday, January 03, 2010
Saturday, January 02, 2010
"Dear Cancer" - Varian RapidArc's Letter Writing Campaign "Dear Cancer"
Note: at this moment the website shows that 1,770+ letters have been written, only 14 ovarian cancer contributions
(to check out the website click on the logo for further information)
Remembering Kat (Star) Rosenthal - Vancouver obituary Jan 2, 2010
add your opinions
friend
,
Kat
,
Laurie
,
obituary
,
ovarian cancer
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer: A Panacea or Just an Obstacle Course for the Patient?
comment: although this discussion is related to colorectal cancer, awareness of these concerns is relevant to our community, I believe
Journal of Pediatric Surgery : Can we preoperatively risk stratify ovarian masses for malignancy?
"1- to 8-year age group had the highest percentage of malignancies"
Friday, January 01, 2010
Single agent carboplatin versus carboplatin plus pegylated liposomal doxorubicin in recurrent ovarian cancer: Final survival results of a SWOG ph 111
Single agent carboplatin versus carboplatin plus pegylated liposomal doxorubicin in recurrent ovarian cancer: Final survival results of a SWOG (S0200) phase 3 randomized trial
"For currently unknown reasons, administering PLD with carboplatin appears to substantially reduce the incidence of platinum-associated hypersensitivity reactions."
Comparison of extended colectomy and limited resection in patients with Lynch syndrome
includes prophylactic (preventative) surgery
Guidelines for the management of ovarian cancer during pregnancy.
"If chemotherapy is indicated, we recommend delaying administration, if possible, until after the delivery or at least after 20 weeks in order to minimize the potential fetal toxicity".
Does the use of diagnostic PET/CT cause stage migration in patients with primary advanced ovarian cancer?
Note: It's unfortunate that early stages of ovarian cancers were not included in this study.
Thursday, December 31, 2009
Ovarian metastases from breast cancer
"Ovarian disease (cancer) was diagnosed at a median of 5 years after breast cancer. Seventy-five percent of patients were asymptomatic, and advanced-stage pelvic extent or extra-abdominal metastases were observed in 41.5% of patients. The median survival was 3 years..."
add your opinions
breast
,
metastases
,
ovarian
,
survival
Safety Considerations and Potential Interactions of Vitamins: Should Vitamins Be Considered Drugs?
"...A, E, D can cause serious adverse events."
Identifying novel autoantibody signatures in ovarian cancer
CONCLUSIONS: Protein microarrays are suitable for autoantibody discovery in ovarian cancer but the signatures are of low frequency.
Subscribe to:
Posts
(
Atom
)
